Intellia Therapeutics
Price & Volume
Stats
See moreOpen | $8.51 |
Previous Close | $8.67 |
Day Range | $8.41-$8.87 |
52W Range | $5.90-$28.25 |
Market Cap | $1B |
Shares Short | 39M |
Financials
See moreRevenue (12 Mos) | $57.5M |
Revenue Growth (YoY) | 51.3% |
Gross Profit (12 Mos) | -$352.3M |
Diluted EPS | -$4.25 |
News
See moreYahoo Finance • 2 days ago
Intellia cut to Peer Perform at Wolfe Research on Nex-z safety issues
Yahoo Finance • 4 days ago
Intellia Therapeutics Presents Positive Longer-Term Phase 1 Data of Nexiguran Ziclumeran (nex-z) in Patients with Transthyretin (ATTR) Amyloidosis with Cardiomyopathy
Yahoo Finance • 4 days ago
Cathie Wood's Ark Invest weekly moves: Adds to ACHR and CRSP, trims positions in ROKU and SOFI
About
CEO | Dr. John M. Leonard M.D. |
Address | 40 Erie Street, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 403 |
